R-CEOP 1-8 regimen for treatment of elderly patients with diffuse large B-cell lymphoma

被引：0
|
作者：
Bascialla, Linda [1 ]
Marelli, Maria [1 ]
Chini, Claudio [1 ]
Proserpio, Ilaria [1 ]
Gueli, Rossana [1 ]
Pinotti, Graziella [1 ]
机构：
[1] Osped Circolo & Fdn Macchi, Varese, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 201
页数：2
相关论文
共 50 条
  • [1] Excellent Outcomes with R-CEOP for Diffuse Large B-Cell Lymphoma in Elderly Patients Not Eligible for Anthracyclines
    Grech, M.
    Gauci, J.
    Theuma, K. -B.
    Gatt, A.
    Camilleri, D. -J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 86 - 87
  • [2] Inferior outcomes with R-CEOP for patients with diffuse large B-cell lymphoma and cardiovascular comorbidities
    Puckrin, Robert
    Ghosh, Sunita
    Peters, Anthea
    Stewart, Douglas
    LEUKEMIA & LYMPHOMA, 2022, 63 (03) : 583 - 590
  • [3] R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma
    Diana Al-Sarayfi
    Frederik O. Meeuwes
    Müjde Durmaz
    Djamila E. Issa
    Rolf E. Brouwer
    Aart Beeker
    Anna van Rhenen
    Pim G. N. J. Mutsaers
    Lara H. Böhmer
    Marjolein W. M. van der Poel
    Liane te Boome
    Tom van Meerten
    Martine E. D. Chamuleau
    Josée M. Zijlstra
    Mirian Brink
    Marcel Nijland
    Blood Cancer Journal, 12
  • [4] R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma
    Al-Sarayfi, Diana
    Meeuwes, Frederik O.
    Durmaz, Mujde
    Issa, Djamila E.
    Brouwer, Rolf E.
    Beeker, Aart
    van Rhenen, Anna
    Mutsaers, Pim G. N. J.
    Bohmer, Lara H.
    van der Poel, Marjolein W. M.
    te Boome, Liane
    van Meerten, Tom
    Chamuleau, Martine E. D.
    Zijlstra, Josee M.
    Brink, Mirian
    Nijland, Marcel
    BLOOD CANCER JOURNAL, 2022, 12 (09)
  • [5] Phase II study of R-CEOP 1-8 for aggressive non-Hodgkin lymphoma in elderly patients
    Marelli, M.
    Bascialla, L.
    Chini, C.
    Proserpio, I
    Gueli, R.
    Pinotti, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI57 - XI57
  • [6] Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria
    Rashidi, Armin
    Oak, Eunhye
    Carson, Kenneth R.
    Wagner-Johnston, Nina D.
    Kreisel, Friederike
    Bartlett, Nancy L.
    LEUKEMIA & LYMPHOMA, 2016, 57 (05) : 1191 - 1193
  • [7] Treatment of elderly patients with diffuse large B-cell lymphoma
    Nösslinger T.
    memo - Magazine of European Medical Oncology, 2016, 9 (1) : 8 - 12
  • [8] Treatment of Primary Mediastinal B-Cell Lymphoma With R-CEOP (Rituximab, Cyclophosphamide, Etoposide, Vincristine, Prednisone)
    Cherukuri, Sundar, V
    Sureen, Amit
    Infante, Taylor
    Rajendran, Nevetha
    Padilla, Osvaldo
    Gaur, Sumit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [9] R-CHOP with Etoposide Substituted for Doxorubicin (R-CEOP): Excellent Outcome in Diffuse Large B Cell Lymphoma for Patients with a Contraindication to Anthracyclines
    Moccia, Alden A.
    Schaff, Kimberly
    Hoskins, Paul
    Klasa, Richard
    Savage, Kerry J.
    Shenkier, Tamara
    Gascoyne, Randy D.
    Connors, Joseph M.
    Sehn, Laurie H.
    BLOOD, 2009, 114 (22) : 170 - 170
  • [10] Efficacy of RCDOP regimen in the treatment of patients with diffuse large B-cell lymphoma
    曹怡文
    China Medical Abstracts(Internal Medicine), 2018, 35 (03) : 187 - 187
12345